| April 10, 2020 |
H.R.6482 |
To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes. |
11 |
Bipartisan |
Referred to the Subcommittee on Oversight and Investigations. |
| March 2, 2020 |
H.R.6049 |
To amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain. |
5 |
Bipartisan |
Referred to the House Committee on Energy and Commerce. |
| Feb. 14, 2020 |
H.R.5916 |
To require providers of health care products and services to publicly disclose point-of-sale cash prices. |
4 |
All Republicans |
Referred to the House Committee on Energy and Commerce. |
| July 17, 2019 |
H.R.3805 |
To reform prescription drug pricing and reduce out-of-pocket costs by ensuring consumers benefit from negotiated rebates. |
0 |
|
Referred to the Subcommittee on Health. |
| July 13, 2017 |
H.RES.443 |
Recognizing the importance and effectiveness of trauma-informed care. |
14 |
Bipartisan |
Motion to reconsider laid on the table Agreed to without objection. |
| Dec. 5, 2017 |
H.R.4552 |
To amend title XVIII of the Social Security Act to establish rules for payment for graduate medical education (GME) costs for hospitals that establish a new medical residency training program after hosting resident rotators for short durations. |
8 |
Bipartisan |
Referred to the Subcommittee on Health. |
Searching...